Long-term management of asthma

被引:5
|
作者
S. K. Kabra
Rakesh Lodha
机构
[1] All India Institute of Medical Sciences,Department of Pediatrics
关键词
Long-term management of asthma; Inhaled steroids; Leukotriene antagonists ketotifen;
D O I
10.1007/BF02722747
中图分类号
学科分类号
摘要
Long-term management of asthma includes identification and avoidance of precipitating factors of asthma, pharmacotherapy and home management plan. Common precipitating factors include viral upper respiratory infections, exposure to smoke, dust, cold food and cold air. Avoidance of common precipitating factors has been shown to help in better control of asthma. Pharmacotherapy is the main stay of treatment of asthma. Commonly used drugs for better control of asthma are long and short acting bronchodilators, mast cell stabilizers, inhaled steroids, theophylline and steroid sparing agents. After assessment of severity most appropriate medications are selected. For mild episodic asthma the medications are short acting beta agonists as and when required. For mild persistent asthma: as and when required bronchodilators along with a daily maintenance treatment in form of low dose inhaled steroids or cromolyn or oral theophylline or leukotriene antagonists are required. Moderate persistent asthma should be treated with inhaled steroids along with long acting beta agonists for symptom control. For severe persistent asthma the recommended treatment includes inhaled steroids, long acting beta agonists with or without theophylline. If symptoms are not well controlled, a minimal dose of oral prednisolone preferably on alternate days may be needed in few patients. Patients should be followed up every 8–12 weeks. On each follow up visit patients should be examined by a doctor, compliance to medications should be checked and actual inhalation technique is observed. Depending on the assessment, medications may be decreased or stepped up. For exercise induced bronchoconstriction: cromolyn, short or long acting beta agonists or leukotriene antagonists may be used. In children with seasonal asthma, maintenance treatment according to assessed severity should be started 2 weeks in advance and continued throughout the season. These patients should be reassessed after discontinuing the treatment. Parents should be given a written plan for management of acute exacerbation at home
引用
收藏
页码:63 / 72
页数:9
相关论文
共 17 条
  • [11] EFFECTS OF LONG-TERM USE OF HIGH-DOSE INHALED STEROIDS ON BONE-DENSITY AND CALCIUM-METABOLISM
    BOULET, LP
    GIGUERE, MC
    MILOT, J
    BROWN, J
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1994, 94 (05) : 796 - 803
  • [12] THE CURRENT PLACE OF BETA-2-AGONISTS IN THE MANAGEMENT OF ASTHMA
    SVEDMYR, N
    LUNG, 1990, 168 : 105 - 110
  • [13] When and how to modify the management of asthma in children over the age of 4
    de Blic, J.
    Deschildre, A.
    Pin, I.
    Dubus, J. -C.
    REVUE DES MALADIES RESPIRATOIRES, 2009, 26 (08) : 827 - 835
  • [14] A health care navigation tool assesses asthma self-management and health literacy
    Perez, Luzmercy
    Morales, Knashawn H.
    Klusaritz, Heather
    Han, Xiaoyan
    Huang, Jingru
    Rogers, Marisa
    Bennett, Ian M.
    Rand, Cynthia S.
    Ndicu, Grace
    Apter, Andrea J.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 138 (06) : 1593 - +
  • [15] Health literacy and asthma management among African-American adults: an interpretative phenomenological analysis
    Melton, Courtnee
    Graff, Carolyn
    Holmes, Gretchen Norling
    Brown, Lawrence
    Bailey, Jim
    JOURNAL OF ASTHMA, 2014, 51 (07) : 703 - 713
  • [16] Health beliefs, treatment preferences and complementary and alternative medicine for asthma, smoking and lung cancer self-management in diverse Black communities
    George, Maureen
    PATIENT EDUCATION AND COUNSELING, 2012, 89 (03) : 489 - 500
  • [17] Equally efficacious asthma management with budesonide 800 mu g administered by Turbuhaler(R) or with beclomethasone dipropionate >=1500 mu g given through a pressurized metered-dose inhaler with spacer
    Piquet, J
    Zuck, P
    Dugue, P
    Grivaux, M
    Brun, P
    Severac, JC
    Ostinelli, J
    Cheeseman, KH
    Bart, F
    Benichou, M
    Delhoume, J
    Fournier, E
    Homasson, J
    Kelkel, E
    Pujet, J
    Lebas, FX
    Muller, D
    Grosbois, J
    Prudhomme, A
    Steenhouver, F
    Donikyan, D
    Herer, B
    Balmes, P
    Bernard, P
    Ravel, T
    Jarsaillon, E
    Berrisoul, F
    Piperno, D
    Grosclaude, M
    ADVANCES IN THERAPY, 1996, 13 (01) : 38 - 50